Zai Lab Limited

Healthcare · Biotechnology · China

Last price 22.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.78B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacter...